Standard Chartered Targets Higher Profitability With Major Workforce Cuts 
The American mass exodus to Canada amid Trump 2.0 has yet to materialize 
Dollar Holds Near Six-Week High as Iran War Fuels Inflation Fears and Boosts Fed Rate Hike Bets 
Samsung, Union Edge Closer to Deal as Strike Threat Looms 
Why have so few atrocities ever been recognised as genocide? 
Asian Stocks Rally as Nvidia Earnings Boost Tech Shares, Samsung Jumps on Wage Deal 
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 
New Zealand Budget 2026: Government Plans Major Public Service Job Cuts Ahead of Election 
Nvidia Earnings in Focus as U.S. Stock Futures Hold Steady Amid Rising Treasury Yields 
OpenAI Expands Globally with First Overseas AI Lab in Singapore 
Why financial hardship is more likely if you’re disabled or sick 
GameStop Raises eBay Stake to 6.6% as Ryan Cohen Pushes $56 Billion Takeover Bid 
Columbia Student Mahmoud Khalil Fights Arrest as Deportation Case Moves to New Jersey 
Thyssenkrupp to Shut Down Indiana Automotive Plant by March 2026 
Hindustan Unilever (HUL) will invest in Zywie Ventures (OZiva) and Nutritionalab (Wellbeing Nutrition) to enter the health and well-being business category.
Unilever’s Indian subsidiary will initially acquire a 51 percent equity stake in OZiva, before purchasing the rest in three years.
A plant-based and clean-label consumer wellness brand, OZiva supplies lifestyle protein, hair and beauty supplements, and women’s health solutions.
OZiva’s current team will continue to operate all business functions.
Meanwhile, HUL is buying a 19.8 percent interest in Wellbeing Nutrition. The company’s product range includes marine collagen powder, Melts oral strips and health capsules. The current Wellbeing Nutrition team, led by founder and CEO Avnish Chhabria, will continue to operate the business.
According to Sanjiv Mehta, HUL’s CEO and managing director, the strategic investments give them an entry into the fast-growing health and wellbeing category.
Mehta added that HUL is well-positioned to support further scale-up of these businesses through our R&D, market development, distribution capabilities, and Unilever’s global health and wellbeing expertise.
Both transactions are set for completion within three months.
